Article info
PDFCardiac risk factors and prevention
Original research article
Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease
- Correspondence to Dr Frank L J Visseren, Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, The Netherlands; F.L.J.Visseren{at}umcutrecht.nl
Citation
Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease
Publication history
- Received October 16, 2017
- Revised March 12, 2018
- Accepted March 15, 2018
- First published April 5, 2018.
Online issue publication
September 27, 2018
Article Versions
- Previous version (5 April 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.